871709-84-1

Usage

Uses

Used in Medicinal Chemistry:
3-Amino-1H-indazole-5-carboxylic acid is used as a chemical intermediate for the synthesis of various pharmaceutical compounds. Its indazole ring and functional groups can be modified to create new molecules with potential therapeutic properties.
Used in Pharmaceutical Research:
3-Amino-1H-indazole-5-carboxylic acid is used as a research tool to study the structure-activity relationships of indazole-based compounds. This can help in the development of new drugs with improved efficacy and reduced side effects.
Used in Drug Design:
3-Amino-1H-indazole-5-carboxylic acid is used as a starting point for the design of new drugs targeting specific biological pathways or receptors. Its structural features can be exploited to create molecules with high selectivity and potency.
Used in Drug Discovery:
3-Amino-1H-indazole-5-carboxylic acid is used in high-throughput screening assays to identify potential drug candidates with desired biological activities. Its presence in these assays can help in the discovery of new therapeutic agents.

Upstream product

• 218301-22-5 2-fluoro-5-formylbenzonitrile 
• 77771-02-9 3-bromo-4-fluorobenzaldehyde 
• 171050-06-9 3-cyano-4-fluorobenzoic acid 

Relevant academic research and scientific papers

Novel indazole derivatives, and use thereof

The present invention refers to novel indazole derivatives, or pharmaceutically acceptable salts; and including DYRK1A DYRK1B active ingredient (Dual non-specificity tyrosine phosphorylation in a non-regulated kinase 1a) or a pharmaceutical composition for preventing or treating related disorders are disclosed. (by machine translation)

COMPOSITION FOR INDUCING CELL REPROGRAMMING

The present invention relates to a composition for inducing cell reprogramming. The indazole derivative compound contained in the composition of the present invention shows an improved biological profile and at the same time can perform efficient cell rep

N1/N2-Lactam Acetyl-CoA carboxylase inhibitors

The invention provides a compound of Formula (I) or a pharmaceutically acceptable salt thereof; wherein G is R1, R2 and R3 are as described herein; pharmaceutical compositions thereof; and the use thereof in treating diseases, conditions or disorders modulated by the inhibition of an acetyl-CoA carboxylase enzyme(s) in an animal

3-AMINOINDAZOLES

Novel 3-aminoindazoles of formula (I) are SGK-inhibitors and can be used for treating SGK-related diseases and illnesses such as diabetes, obesity, metabolic syndrome (dyslipidaemia), systemic and pulmonary hypertonia, cardiovascular diseases and renal diseases, and generally any type of fibroses and inflammatory processes.